European Society for Medical Oncology Congress

The latest news from ESMO, including researcher interviews and physician perspective.


Meeting News Coverage

Alisertib may benefit certain patients with neuroendocrine prostate cancer

October 8, 2016
COPENHAGEN, Denmark — Alisertib monotherapy may be effective in certain patients with clinical or pathologically defined neuroendocrine…
Meeting News Coverage

Adjuvant ipilimumab extends survival in stage III melanoma

October 8, 2016
COPENHAGEN, Denmark — Adjuvant therapy with ipilimumab significantly extended survival compared with placebo among patients who underwent…
Meeting News Coverage

Ribociclib plus letrozole extends PFS in hormone receptor–positive, HER-2–negative advanced breast cancer

October 8, 2016
COPENHAGEN, Denmark — The addition of ribociclib to letrozole significantly extended PFS in postmenopausal women with hormone…
Meeting News Coverage

Novel agent crosses blood-brain barrier to treat CNS metastases from breast cancer

October 8, 2016
COPENHAGEN, Denmark — ANG1005, a novel peptide–paclitaxel conjugate, demonstrated activity and crossed the blood-brain barrier in women…
Meeting News CoveragePerspective

Dabrafenib shows promise for BRAF V600–mutated pediatric low-grade gliomas

October 7, 2016
COPENHAGEN, Denmark — Targeted treatment with dabrafenib induced a high rate of response and appeared safe in pediatric patients with BRAF
Meeting News Coverage

Abemaciclib effective for Ki67 reduction in certain postmenopausal women with breast cancer

October 7, 2016
COPENHAGEN, Denmark — Neoadjuvant abemaciclib with or without anastrozole led to significantly greater reductions in tissue Ki67 after 2 weeks…
Meeting News CoveragePerspective

Abiraterone acetate may yield clinical benefit in subset of women with ovarian cancer

October 7, 2016
COPENHAGEN, Denmark — A subset of women with recurrent epithelial ovarian cancer may achieve sustained clinical benefit from abiraterone…
Meeting News CoveragePerspective

Derived neutrophil-to-lymphocyte ratio predicts DFS in early breast cancer

October 7, 2016
COPENHAGEN, Denmark — The derived neutrophil-to-lymphocyte ratio predicted shorter DFS among women with HER-2–enriched and nonluminal…
Meeting News CoveragePerspective

Selinexor demonstrates antitumor activity in heavily pretreated ovarian, endometrial cancers

October 7, 2016
COPENHAGEN, Denmark — Single-agent selinexor demonstrated antitumor activity in heavily pretreated patients with ovarian or endometrial…
Meeting News Coverage

Neoadjuvant nivolumab feasible, safe in early-stage resectable NSCLC

October 7, 2016
COPENHAGEN, Denmark — Neoadjuvant treatment with the PD-1 inhibitor nivolumab demonstrated activity in patients with early-stage resectable…